CRMD · CorMedix Inc.
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-02-04 | Todisco Joseph |
Executive Vice President |
Award↑
Filing footnotes — Common Stock (Direct)
Represents the achievement of performance stock units ("PSUs") upon the determination of the Compensation Committee of the Issuer that the performance conditions specific to the first of three performance periods were met with respect to the PSUs granted to the Reporting Person on January 2, 2025. The PSUs are subject to vesting upon satisfaction of time-based vesting conditions by the Reporting Person. |
Common Stock
|
77,156 |
| 2026-02-04 | Hurlburt Elizabeth |
Chief Operating Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Represents the achievement of performance stock units ("PSUs") upon the determination of the Compensation Committee of the Issuer that the performance conditions specific to the first of three performance periods were met with respect to the PSUs granted to the Reporting Person on January 2, 2025. The PSUs are subject to vesting upon satisfaction of time-based vesting conditions by the Reporting Person. |
Common Stock
|
36,006 |
| 2026-02-04 | Zelnick Kaufman Beth |
Chief Legal Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Represents the achievement of performance stock units ("PSUs") upon the determination of the Compensation Committee of the Issuer that the performance conditions specific to the first of three performance periods were met with respect to the PSUs granted to the Reporting Person on January 2, 2025. The PSUs are subject to vesting upon satisfaction of time-based vesting conditions by the Reporting Person. |
Common Stock
|
36,006 |
| 2026-01-26 | DUNTON ALAN W |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares represent restricted stock units issued on January 26, 2026. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units will vest in full on January 26, 2027, subject to continued service on the vesting date. |
Common Stock
|
30,453 |
| 2026-01-26 | Stewart Robert A |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares represent restricted stock units issued on January 26, 2026. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units will vest in full on January 26, 2027, subject to continued service on the vesting date. |
Common Stock
|
30,453 |
| 2026-01-26 | Duncan Gregory Scott |
Director, CHIEF EXECUTIVE OFFICER |
Award↑
Filing footnotes — Common Stock (Direct)
These shares represent restricted stock units issued on January 26, 2026. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units will vest in full on January 26, 2027, subject to continued service on the vesting date. |
Common Stock
|
30,453 |
| 2026-01-26 | Lefkowitz Steven W |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares represent restricted stock units issued on January 26, 2026. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units will vest in full on January 26, 2027, subject to continued service on the vesting date. |
Common Stock
|
30,453 |
| 2026-01-26 | Kaplan Myron |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares represent restricted stock units issued on January 26, 2026. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units will vest in full on January 26, 2027, subject to continued service on the vesting date. |
Common Stock
|
30,453 |
| 2026-01-26 | Dillione Janet |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares represent restricted stock units issued on January 26, 2026. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units will vest in full on January 26, 2027, subject to continued service on the vesting date. |
Common Stock
|
30,453 |
| 2026-01-23 | Blum Susan |
Chief Financial Officer |
Tax↓
|
Common Stock
|
9,767 |
| 2026-01-23 | Todisco Joseph |
Executive Vice President |
Tax↓
|
Common Stock
|
27,306 |
| 2026-01-23 | Zelnick Kaufman Beth |
Chief Legal Officer |
Award↑
Filing footnotes — Common Stock (Direct)
These shares represent restricted stock units granted on 01/23/2026. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant. |
Common Stock
|
72,820 |
| 2026-01-23 | Zelnick Kaufman Beth |
Chief Legal Officer |
Tax↓
|
Common Stock
|
8,803 |
| 2026-01-23 | Hurlburt Elizabeth |
Chief Operating Officer |
Award↑
Filing footnotes — Common Stock (Direct)
These shares represent restricted stock units granted on 01/23/2026. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant. |
Common Stock
|
93,010 |
| 2026-01-23 | Hurlburt Elizabeth |
Chief Operating Officer |
Tax↓
|
Common Stock
|
10,778 |
| 2026-01-23 | Todisco Joseph |
Executive Vice President |
Award↑
Filing footnotes — Common Stock (Direct)
These shares represent restricted stock units granted on 01/23/2026. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant. |
Common Stock
|
225,900 |
| 2026-01-23 | Blum Susan |
Chief Financial Officer |
Award↑
Filing footnotes — Common Stock (Direct)
These shares represent restricted stock units granted on 01/23/2026. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant. |
Common Stock
|
72,820 |
| 2026-01-21 | Dillione Janet |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was executed in multiple trades at prices ranging from $6.85 to $6.90, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected |
Common Stock
|
10,000 |
| 2026-01-17 | Todisco Joseph |
Executive Vice President |
Tax↓
|
Common Stock
|
22,665 |
| 2026-01-16 | Todisco Joseph |
Executive Vice President |
Convert↑
Filing footnotes — Common Stock (Direct)
The Reporting Person acquired stock through the exercise of options granted on 5/10/2022. The Reporting Person paid the exercise price in cash. No sales of stock were made. |
Common Stock
|
29,585 |
| 2026-01-16 | Todisco Joseph |
Executive Vice President |
Convert↓
Filing footnotes — Stock Option (Right to Buy Common Stock) (Direct)
These options were granted on 5/10/2022. These options vest over four years in four equal installments on the first four anniversaries of the grant date, subject to continued employment through the applicable vesting date. |
Stock Option (Right to Buy Common Stock)
|
29,585 |
| 2026-01-12 | Lefkowitz Steven W |
Director |
Convert↓
Filing footnotes — Stock Option (Right to Buy Common Stock) (Direct)
These stock options, representing a right to purchase 15,000 shares of Common Stock, were granted on 02/25/2020. These stock options are fully vested. |
Stock Option (Right to Buy Common Stock)
|
15,000 |
| 2026-01-12 | Todisco Joseph |
Executive Vice President |
Tax↓
Filing footnotes — Common Stock (Direct)
This transaction is being reported late due to an inadvertent administrative error. |
Common Stock
|
17,417 |
| 2026-01-12 | Hurlburt Elizabeth |
Chief Operating Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
This transaction is being reported late due to an inadvertent administrative error. |
Common Stock
|
5,794 |
| 2026-01-12 | Lefkowitz Steven W |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
The Reporting Person acquired stock through the exercise of options granted on 02/25/2020. The Reporting Person paid the exercise price in cash. No sales of stock were made. |
Common Stock
|
15,000 |
| 2026-01-08 | Seckler Michael David |
Chief Commercial Officer |
Award↑
Filing footnotes — Common Stock (Direct)
These Restricted Stock Units were granted on 01/08/2026. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest over four years in four equal installments on the first four anniversaries of the grant date, subject to continued employment through the applicable vesting date. |
Common Stock
|
133,156 |
| 2026-01-08 | Seckler Michael David |
Chief Commercial Officer |
Other↑
|
No Securities Owned
|
0 |
| 2026-01-02 | Zelnick Kaufman Beth |
Chief Legal Officer |
Tax↓
|
Common Stock
|
11,333 |
| 2026-01-02 | Hurlburt Elizabeth |
Chief Operating Officer |
Tax↓
|
Common Stock
|
10,895 |
| 2025-12-30 | DUNTON ALAN W |
Director |
Sell↓
|
Common Stock
|
20,000 |
| 2025-12-30 | DUNTON ALAN W |
Director |
Convert↓
Filing footnotes — Stock Option (Right to Buy Common Stock) (Direct)
These options were granted on 2/22/2022. These options are fully vested. |
Stock Option (Right to Buy Common Stock)
|
20,000 |
| 2025-12-30 | DUNTON ALAN W |
Director |
Convert↑
|
Common Stock
|
20,000 |
| 2025-12-18 | Todisco Joseph |
Executive Vice President |
Convert↑
|
Common Stock
|
30,000 |
| 2025-12-18 | Todisco Joseph |
Executive Vice President |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was executed in multiple trades at prices ranging from $12.00 to $12.02, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. |
Common Stock
|
30,000 |
| 2025-12-18 | Todisco Joseph |
Executive Vice President |
Convert↓
Filing footnotes — Stock Option (Right to Buy Common Stock) (Direct)
These options were granted on 01/14/2023. These options vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant. |
Stock Option (Right to Buy Common Stock)
|
30,000 |
| 2025-12-09 | Dillione Janet |
Director |
Convert↑
|
Common Stock
|
19,000 |
| 2025-12-09 | Lefkowitz Steven W |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was executed in multiple trades at prices ranging from $11.87 to $11.92, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. |
Common Stock
|
40,000 |
| 2025-12-09 | Dillione Janet |
Director |
Convert↓
Filing footnotes — Stock Option (Right to Buy Common Stock) (Direct)
These options were granted on 02/21/2016. These options are fully vested. |
Stock Option (Right to Buy Common Stock)
|
19,000 |
| 2025-12-09 | Dillione Janet |
Director |
Convert↑
|
Common Stock
|
15,000 |
| 2025-12-09 | Dillione Janet |
Director |
Convert↓
Filing footnotes — Stock Option (Right to Buy Common Stock) (Direct)
These options were granted on 02/25/2020. These options are fully vested. |
Stock Option (Right to Buy Common Stock)
|
15,000 |
| 2025-12-09 | Dillione Janet |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was executed in multiple trades at prices ranging from $12.00 to $12.02, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected |
Common Stock
|
34,000 |
| 2025-12-02 | Dillione Janet |
Director |
Convert↓
Filing footnotes — Stock Option (Right to Buy Common Stock) (Direct)
These options were granted on 03/05/2024. These options are fully vested. |
Stock Option (Right to Buy Common Stock)
|
19,323 |
| 2025-12-02 | Dillione Janet |
Director |
Convert↑
|
Common Stock
|
12,210 |
| 2025-12-02 | Dillione Janet |
Director |
Convert↓
Filing footnotes — Stock Option (Right to Buy Common Stock) (Direct)
These options were granted on 02/22/2022. These options are fully vested. |
Stock Option (Right to Buy Common Stock)
|
12,210 |
| 2025-12-02 | Dillione Janet |
Director |
Convert↑
|
Common Stock
|
19,323 |
| 2025-12-02 | Dillione Janet |
Director |
Sell↓
|
Common Stock
|
46,657 |
| 2025-12-02 | Dillione Janet |
Director |
Convert↓
Filing footnotes — Stock Option (Right to Buy Common Stock) (Direct)
These options were granted on 01/14/2023. These options are fully vested. |
Stock Option (Right to Buy Common Stock)
|
15,124 |
| 2025-12-02 | Dillione Janet |
Director |
Convert↑
|
Common Stock
|
15,124 |
| 2025-11-24 | Dillione Janet |
Director |
Convert↓
Filing footnotes — Stock Option (Right to Buy Common Stock) (Direct)
These options were granted on 02/22/2022. These options are fully vested. |
Stock Option (Right to Buy Common Stock)
|
7,790 |
| 2025-11-24 | Dillione Janet |
Director |
Convert↓
Filing footnotes — Stock Option (Right to Buy Common Stock) (Direct)
These options were granted on 03/05/2024. These options are fully vested. |
Stock Option (Right to Buy Common Stock)
|
5,677 |